Published in Gastroenterology on September 02, 2007
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology (2009) 1.72
Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest (2009) 1.45
Identification and functional characterization of TMEM16A, a Ca2+-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium. J Biol Chem (2010) 1.19
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology (2011) 1.07
Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. Am J Physiol Gastrointest Liver Physiol (2011) 1.05
Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology (2009) 1.05
Endocrine and paracrine role of bile acids. World J Gastroenterol (2008) 1.02
Physiology of cholangiocytes. Compr Physiol (2013) 1.00
Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP. Am J Physiol Gastrointest Liver Physiol (2009) 0.97
Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference. Hepatology (2008) 0.96
Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal (2013) 0.95
Adenosine triphosphate release and purinergic (P2) receptor-mediated secretion in small and large mouse cholangiocytes. Hepatology (2010) 0.94
Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid. Channels (Austin) (2012) 0.85
Calcium signaling and the secretory activity of bile duct epithelia. Cell Calcium (2014) 0.84
Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology (2015) 0.82
Thinking outside the cell: the role of extracellular adenosine triphosphate in bile formation. Gastroenterology (2007) 0.81
Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat. PLoS One (2011) 0.81
Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells. Cell Commun Signal (2015) 0.80
Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells. J Gastroenterol (2013) 0.80
Role of AE2 for pHi regulation in biliary epithelial cells. Front Physiol (2014) 0.80
Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes. World J Gastrointest Pathophysiol (2010) 0.78
Calcium signaling in the liver. Compr Physiol (2013) 0.78
Calcium signaling and secretion in cholangiocytes. Pancreatology (2015) 0.77
Regulation of mechanosensitive biliary epithelial transport by the epithelial Na(+) channel. Hepatology (2015) 0.77
Adenylyl cyclases in the digestive system. Cell Signal (2014) 0.77
Liver disease in cystic fibrosis. Prz Gastroenterol (2014) 0.76
Ezrin finds its groove in cholangiocytes. Hepatology (2015) 0.76
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Hepatology (2016) 0.75
Huqi San-Evoked Rat Colonic Anion Secretion through Increasing CFTR Expression. Evid Based Complement Alternat Med (2015) 0.75
Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12. Am J Pathol (2015) 0.75
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology (2006) 2.61
The cholangiopathies: disorders of biliary epithelia. Gastroenterology (2004) 2.38
Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc (2009) 2.08
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. J Hepatol (2007) 1.83
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology (2003) 1.79
Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells. Hepatology (2002) 1.79
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology (2009) 1.72
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology (2013) 1.65
Pathophysiology of cholangiopathies. J Clin Gastroenterol (2005) 1.63
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut (2010) 1.59
Development of the bile ducts: essentials for the clinical hepatologist. J Hepatol (2012) 1.55
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl (2002) 1.50
"The city of Hepar": rituals, gastronomy, and politics at the origins of the modern names for the liver. J Hepatol (2011) 1.42
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Emerging roles of Notch signaling in liver disease. Hepatology (2014) 1.39
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology (2010) 1.31
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology (2009) 1.29
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol (2007) 1.26
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol (2008) 1.12
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output. Hepatology (2011) 1.11
Epithelial-mesenchymal interactions in biliary diseases. Semin Liver Dis (2011) 1.11
Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes. Hepatology (2012) 1.09
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology (2011) 1.07
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol (2005) 1.04
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice. J Hepatol (2013) 1.04
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. Hepatology (2008) 1.03
Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol (2010) 1.02
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J Pediatr (2009) 1.01
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl (2002) 0.99
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib. Hepatology (2012) 0.99
Notch signaling in hepatocellular carcinoma: guilty in association! Gastroenterology (2012) 0.98
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One (2009) 0.96
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology (2011) 0.96
Functional anatomy of normal bile ducts. Anat Rec (Hoboken) (2008) 0.96
Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis. Clin Res Hepatol Gastroenterol (2013) 0.92
Vascular biology of the biliary epithelium. J Gastroenterol Hepatol (2013) 0.91
Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis. Hepatology (2002) 0.91
Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis. Hepatology (2013) 0.88
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One (2011) 0.88
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. Dig Liver Dis (2010) 0.87
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. Gastroenterology (2005) 0.86
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl (2010) 0.85
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol (2012) 0.85
Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat. Dig Dis (2015) 0.83
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Transpl Int (2006) 0.83
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. J Hepatol (2012) 0.83
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. Oncol Rep (2013) 0.82
Hybrid cardiomyocytes derived by cell fusion in heterotopic cardiac xenografts. FASEB J (2006) 0.81
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. J Clin Gastroenterol (2007) 0.81
Extended right split liver graft for primary transplantation in children and adults. Transpl Int (2006) 0.81
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved? J Hepatol (2012) 0.80
Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats. Virchows Arch (2004) 0.80
The prognosis of perihilar cholangiocarcinoma after radical treatments. Hepatology (2012) 0.79
Neural cell adhesion molecule and polysialic acid in ductular reaction: the puzzle is far from completed, but the picture is becoming more clear. Hepatology (2014) 0.79
Therapy of inflammatory bowel diseases in pregnancy and lactation. Expert Opin Drug Saf (2009) 0.78
Systemic therapy in hepatocellular carcinoma. Clin Liver Dis (2011) 0.78
Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas (2003) 0.78
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion? Hepatology (2013) 0.77
Incidence and management of colorectal cancer in liver transplant recipients. Clin Colorectal Cancer (2008) 0.76